{"id":7505,"date":"2023-09-27T18:00:00","date_gmt":"2023-09-27T18:00:00","guid":{"rendered":"http:\/\/www.cov19longhaulfoundation.org\/?p=7505"},"modified":"2023-09-27T18:00:00","modified_gmt":"2023-09-27T18:00:00","slug":"researchers-find-immune-response-to-covid-strengthens-over-time","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=7505","title":{"rendered":"Researchers find immune response to COVID strengthens over time"},"content":{"rendered":"\n<p>by Erik Robinson,&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.ohsu.edu\/xd\/\" target=\"_blank\">Oregon Health &amp; Science University<\/a>  JANUARY 25, 2023<\/p>\n\n\n\n<figure class=\"wp-block-image is-style-default\"><img decoding=\"async\" src=\"https:\/\/scx1.b-cdn.net\/csz\/news\/800a\/2023\/researchers-find-immun.jpg\" alt=\"Researchers find immune response to Covid strengthens over time\" title=\"Longitudinal cohort of previously infected vaccinees shows improved variant neutralization compared to vaccination aloneRepresentative focus reduction neutralization test (FRNT) results showing wells infected with live SARS-CoV-2 with the addition of serially diluted serum which were stained and counted (A). Representative focus reduction neutralization curve showing the average neutralization of duplicates as a percent of no serum controls and fit to a dose-response curve to find the 50% neutralizing titer (FRNT50) (B). Live virus FRNT50 measurements against original SARS-CoV-2 (WA1) and the Alpha, Beta, and Gamma variants before and after vaccination (C). Timeline depicting the prevalence of impactful variants in the study location, Oregon, USA (D). Vaccine-only participants are represented by red circles and hybrid immune participants by cyan squares. Error bars represent the geometric mean with 95% confidence intervals. P values in C show the result of Mann-Whitney U tests. All P values are two-tailed and 0.05 was considered significant. For panel C, n=20 for the vaccine only group and n=10 for the prior infection group. Credit: medRxiv (2023). DOI: 10.1101\/2023.01.02.23284120\"\/><figcaption class=\"wp-element-caption\">Longitudinal cohort of previously infected vaccinees shows improved variant neutralization compared to vaccination aloneRepresentative focus reduction neutralization test (FRNT) results showing wells infected with live SARS-CoV-2 with the addition of serially diluted serum which were stained and counted (A). Representative focus reduction neutralization curve showing the average neutralization of duplicates as a percent of no serum controls and fit to a dose-response curve to find the 50% neutralizing titer (FRNT<sub>50<\/sub>) (B). Live virus FRNT<sub>50<\/sub>&nbsp;measurements against original SARS-CoV-2 (WA1) and the Alpha, Beta, and Gamma variants before and after vaccination (C). Timeline depicting the prevalence of impactful variants in the study location, Oregon, USA (D). Vaccine-only participants are represented by red circles and hybrid immune participants by cyan squares. Error bars represent the geometric mean with 95% confidence intervals. P values in C show the result of Mann-Whitney U tests. All P values are two-tailed and 0.05 was considered significant. For panel C, n=20 for the vaccine only group and n=10 for the prior infection group. Credit:&nbsp;<em>medRxiv<\/em>&nbsp;(2023). DOI: 10.1101\/2023.01.02.23284120<\/figcaption><\/figure>\n\n\n\n<p>Immunity from COVID-19 appears to gather strength with more time between vaccination and infection, a new laboratory study from researchers at Oregon Health &amp; Science University suggests. The findings carry implications for vaccine recommendations as the pandemic transitions to an endemic state.<\/p>\n\n\n\n<p>Researchers measured the antibody response in blood samples for a group of people who gained so-called &#8220;hybrid immunity&#8221; through two means: either vaccination followed by a&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/breakthrough+infection\/\">breakthrough infection<\/a>, or by getting vaccinated after contracting COVID-19. They measured the immune response in&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/blood+samples\/\">blood samples<\/a>&nbsp;of 96 generally healthy OHSU employees and found that the immune response was uniformly stronger the longer the time period between vaccination and infection. The longest interval measured was 404 days.<\/p>\n\n\n\n<p>Their findings suggest that&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/vaccine\/\">vaccine<\/a>&nbsp;boosters should be spaced no more frequently than a year apart, at least among healthy people.<\/p>\n\n\n\n<p>&#8220;Longer intervals between natural infection and vaccination appear to strengthen immune response for otherwise healthy people,&#8221; said co-senior author Fikadu Tafesse, Ph.D., associate professor of molecular microbiology and immunology in the OHSU School of Medicine.<\/p>\n\n\n\n<p>The study comes as an&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/advisory+panel\/\">advisory panel<\/a>&nbsp;for the Food and Drug Administration is due to meet Thursday, Jan. 26, to consider the nation&#8217;s COVID-19 vaccine strategy going forward.<\/p>\n\n\n\n<p>Published in the&nbsp;<em>Journal for Clinical Investigation Insight<\/em>, the new research is the latest in a series of laboratory discoveries by OHSU scientists revealing a pattern of strengthened immune response through hybrid immunity. Their findings suggest that the magnitude, potency and breadth of hybrid immune response all increased with a longer time period between exposure to the virus\u2014whether through vaccination or natural infection.<\/p>\n\n\n\n<p>This likely is related to the body&#8217;s immune response maturing over time, said co-senior author Marcel Curlin, M.D., associate professor of medicine (<a href=\"https:\/\/medicalxpress.com\/tags\/infectious+diseases\/\">infectious diseases<\/a>) in the OHSU School of Medicine and medical director of OHSU Occupational Health.<\/p>\n\n\n\n<p>&#8220;The&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/immune+system\/\">immune system<\/a>&nbsp;is learning,&#8221; Curlin said. &#8220;If you&#8217;re going to amplify a response, what this study tells us is that you might want to boost that response after a longer period of learning rather than early after exposure.&#8221;<\/p>\n\n\n\n<p>Further, the research team found that it didn&#8217;t matter whether someone developed hybrid immunity by getting vaccinated after contracting COVID-19 or after a breakthrough infection following vaccination. Both groups developed an equally potent immune response.<\/p>\n\n\n\n<p>The findings suggest long-lasting potency of so-called &#8220;memory cells,&#8221; the B cells that recognize an invading virus and generate protein antibodies to neutralize the virus and its many variants. The authors write that an ever-growing pool of people who have contracted the SARS-CoV-2 virus stand to benefit from vaccination, even if they&#8217;ve delayed it until now.<\/p>\n\n\n\n<p>Relying on natural&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/infection\/\">infection<\/a>&nbsp;alone is a bad idea, &#8220;given the risks of severe illness, long-term complications, and death,&#8221; the authors write.<\/p>\n\n\n\n<p>The researchers say the findings are the latest to point toward the virus evolving to an endemic state.<\/p>\n\n\n\n<p>&#8220;Our results point to a future where inevitable vaccine breakthrough infections would be expected to help build a reservoir of population-level immunity that can help blunt future waves and reduce the opportunity for further viral evolution,&#8221; they write.<\/p>\n\n\n\n<p>The researchers cautioned that the&nbsp;<a href=\"https:\/\/medicalxpress.com\/tags\/immune+response\/\">immune response<\/a>&nbsp;was measured in relatively healthy people, and boosters may be advisable on a more frequent basis among vulnerable people who are older or are immunocompromised.<\/p>\n\n\n\n<p><strong>More information:<\/strong>&nbsp;Timothy A. Bates et al, The time between vaccination and infection impacts immunity against SARS-CoV-2 variants,&nbsp;<em>medRxiv<\/em>&nbsp;(2023).&nbsp;<a href=\"https:\/\/dx.doi.org\/10.1101\/2023.01.02.23284120\" target=\"_blank\" rel=\"noreferrer noopener\">DOI: 10.1101\/2023.01.02.23284120<\/a><\/p>\n\n\n\n<p>Timothy A. Bates et al, An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants,&nbsp;<em>JCI Insight<\/em>&nbsp;(2023). DOI: 10.1172\/jci.insight.165265 ,&nbsp;<a href=\"https:\/\/insight.jci.org\/articles\/view\/165265\" target=\"_blank\" rel=\"noreferrer noopener\">insight.jci.org\/articles\/view\/165265<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>by Erik Robinson,&nbsp;Oregon Health &amp; Science University JANUARY 25, 2023 Immunity from COVID-19 appears to gather strength with more time between vaccination and infection, a new laboratory study from researchers [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7508,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[976,725,836,890,920,607],"tags":[],"class_list":["post-7505","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-acquired-immunity","category-booster-shot","category-immune-system","category-natural-immunity-immune-system","category-pro-vaccine","category-vaccine-news"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/7505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7505"}],"version-history":[{"count":0,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/7505\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/7508"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}